An experimental oral medication for hard-to-treat hypertension is one step closer to approval. According to Fierce Biotech, drugmaker AstraZeneca released new data from Phase III clinical trials that showed significant reductions in average nighttime blood pressure readings among trial participants compared to a placebo. Elevated nighttime blood pressure is associated with increased risk of heart attack, stroke, and other cardiovascular events.
Related Posts
Zinc for colds? Researchers are skeptical
Zinc may be a popular over-the-counter supplement to reduce the severity and duration of common colds, but according to Harvard Health, the benefits may…
July 6, 1957: Musical Meeting
Who knows what would have happened if Paul McCartney had a dentist appointment on July 6, 1957? But it so happens the 15-year-old was free to see the…
Time for Eid: The festival of food and sweets
On April 22, about 2 billion Muslims will wish each other “Eid Mubarak,” or blessed feast, as they break their month-long fast and begin a happy…